Literature DB >> 23173837

Papillary glioneuronal tumour: a review of the literature with two illustrative cases.

A K Demetriades1, S Al Hyassat, S Al-Sarraj, R S Bhangoo, K Ashkan.   

Abstract

We report two cases of papillary glioneuronal tumour (PGNT). One was located in the supratentorial parenchyma and the other was intraventricular. Both patients underwent gross total resection of their tumour and have returned to normal lifestyle. Papillary glioneuronal tumor is a recently described rare cerebral neoplasm. Recently classified by the World Health Organization in 2007 as a Grade I neuronal-glial tumour, these tumours are infrequent lesions that can be challenging to the practising pathologist. Patients commonly present with headaches or seizures, but may be asymptomatic with the mass discovered incidentally. The characteristic radiological, histological and immunohistochemical features are discussed. Surgical excision has been curative in most of the cases with only a handful of cases of recurrence reported. The increasing number of reports in the literature shows how PGNT forms a good example of a newly diagnosed tumour category in evolution. New classifications and re-classifications of broad categories of brain tumours will hopefully lead to a narrower diagnostic, prognostic and therapeutic profile. The even rarer presence of atypia calls for longer follow-up to help elucidate further its biological behaviour.

Entities:  

Mesh:

Year:  2012        PMID: 23173837     DOI: 10.3109/02688697.2012.741735

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  2 in total

1.  Papillary glioneuronal tumor growing slowly for 26 years: illustrative case.

Authors:  Kazuma Shinno; Yoshiki Arakawa; Sachiko Minamiguchi; Yukinori Terada; Masahiro Tanji; Yohei Mineharu; Takayuki Kikuchi; Hironori Haga; Susumu Miyamoto
Journal:  J Neurosurg Case Lessons       Date:  2021-07-05

2.  Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion.

Authors:  Melanie Pages; Ludovic Lacroix; Arnault Tauziede-Espariat; David Castel; Estelle Daudigeos-Dubus; Vita Ridola; Sophie Gilles; Frederic Fina; Felipe Andreiuolo; Marc Polivka; Emmanuele Lechapt-Zalcman; Stephanie Puget; Nathalie Boddaert; Xiao-Qiong Liu; Julia A Bridge; Jacques Grill; Fabrice Chretien; Pascale Varlet
Journal:  Acta Neuropathol Commun       Date:  2015-12-15       Impact factor: 7.801

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.